Point-of-care molecular diagnostics for emerging biological threats designed in weeks rather than months.
AminoAnalytica designs rapid point-of-care molecular diagnostics for emerging biological and pandemic threats, with a goal of developing new tests in weeks versus the 12+ months required by traditional approaches. The company is founded by Abhi (ex-Mercedes F1 engineering) and Adam (Thermo Fisher Scholar, ex-P&G), with Chief Scientist Prof. Stefano Angioletti-Uberti of Imperial College London's computational bionanotechnology group. Their mission is to shift pandemic response from crisis reaction to early prevention. AminoAnalytica is a product of AminoAnalytica.